West Pharmaceutical Services, Inc. Common Stock (NY:WST)

367.23 +3.96 (+1.09%)

Delayed Quote Updated: 3:20 PM EDT, Oct 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about West Pharmaceutical Services, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

18 19 Next >

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST

June 15, 2025

From Pomerantz LLP

Via GlobeNewswire

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services

June 12, 2025

From Faruqi & Faruqi LLP

Via GlobeNewswire

WST Lead Plaintiff Deadline Approaching – WST Stockholders Should Contact Robbins LLP for Information About Leading the West Pharmaceutical Services, Inc. Class Action Lawsuit

June 12, 2025

From Robbins LLP

Via GlobeNewswire

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WST

June 11, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

How Is The Market Feeling About West Pharmaceutical Servs? ↗

June 10, 2025

Via Benzinga

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST

June 10, 2025

From Pomerantz LLP

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Compass Diversified, Civitas, Open Lending, and West Pharmaceutical and Encourages Investors to Contact the Firm

June 09, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

1 S&P 500 Stock with Competitive Advantages and 2 to Steer Clear Of

June 09, 2025

While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural...

Via StockStory

Topics Economy Stocks

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WST

June 08, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST

June 06, 2025

From Pomerantz LLP

Via GlobeNewswire

Thursday's session: top gainers and losers in the S&P500 index ↗

June 05, 2025

Let's have a look at the top S&P500 gainers and losers one hour before the close of the markets of today's session.

Via Chartmill

ROSEN, SKILLED INVESTOR COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WST

June 05, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Avis Budget, Civitas, Open Lending, and West Pharmaceutical and Encourages Investors to Contact the Firm

June 02, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services

June 02, 2025

From Faruqi & Faruqi LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST

June 02, 2025

From Pomerantz LLP

Via GlobeNewswire

If you are a Long-Term Shareholder of DoubleVerify Holdings, Inc. (NYSE: DV); Maison Solutions, Inc. (NASDAQ: MSS); Manhattan Associates, Inc. (NASDAQ: MANH); or West Pharmaceutical Services, Inc. (NYSE: WST), Contact Grabar Law Office Today

June 02, 2025

From Grabar Law Office

Via GlobeNewswire

1 High-Flying Stock with Competitive Advantages and 2 to Brush Off

June 02, 2025

Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match. The flip side though is that these lofty expectations make them particularly...

Via StockStory

Topics Economy

ROSEN, LEADING INVESTOR COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WST

June 01, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of DoubleVerify Holdings, Inc. (NYSE: DV); Treace Medical Concepts, Inc. (NASDAQ: TMCI); Virtu Financial Inc. (NASDAQ: VIRT); and West Pharmaceutical Services, Inc. (NYSE: WST)

May 30, 2025

From Grabar Law Office

Via GlobeNewswire

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WST

May 29, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

WST Investors Have the Opportunity to Lead the West Pharmaceutical Securities Fraud Lawsuit with Faruqi & Faruqi, LLP

May 28, 2025

From Faruqi & Faruqi LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST

May 28, 2025

From Pomerantz LLP

Via GlobeNewswire

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WST

May 26, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WST

May 23, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

WST Investors Have the Opportunity to Lead the West Pharmaceutical Services Securities Fraud Lawsuit with Faruqi & Faruqi, LLP

May 23, 2025

From Faruqi & Faruqi LLP

Via GlobeNewswire

Kirby McInerney LLP Reminds West Pharmaceutical Services, Inc. (WST) Investors of Class Action Filing and Encourages Investors to Contact the Firm

May 22, 2025

From Kirby McInerney LLP

Via Business Wire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Compass Diversified, Digimarc, Elevance Health, and West Pharmaceutical and Encourages Investors to Contact the Firm

May 21, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

ROSEN, LEADING INVESTOR COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WST

May 20, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST

May 18, 2025

From Pomerantz LLP

Via GlobeNewswire

Deadline Alert: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

May 16, 2025

From Glancy Prongay & Murray LLP

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

18 19 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.